Onesource Specl Pharma L
Nifty 500
Smallcap 250
₹1,592.20
+3.26%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.26.
- Sales have compounded about 131% a year over five years.
- Promoters hold a sizeable stake (30.48%).
!Watch-points
- Return on equity is on the lower side at -1.1%.
- Return on capital employed is on the lower side at 0.6%.
- The company reported a net loss in the latest period.
- Recent profit growth (-142%) is slower than the five-year pace (8%).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.62
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreWeak
2 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 18,258 Cr
Current Price₹ 1,592.20
High / Low₹ 1,925.00 / 1,057.00
Stock P/E—
Book Value₹ 509.00
Dividend Yield0%
ROCE0.57%
ROE-1.09%
Face Value₹ 1.00
Debt to Equity0.26
PEG Ratio—
EV / EBITDA33.90
Industry PE35.70
P/B Ratio3.137958
EPS₹ -6.44
Debt₹ 1,504 Cr
PAT Margin-5.20%
Cash PAT₹ 205 Cr
ICR2.49
Promoter Holding30.48%
FII Holding19.19%
DII Holding23.37%
Public Holding26.95%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity